No Detail Found!

Effects of dapagliflozin against streptozotocin and isoproterenol- induced heart failure via investigating NLRP3 and PPAR-γ signaling

Author(s)
Khadija Ijaz Riphah Institute of Pharmaceutical Sciences, Riphah International University,Islamabad,Pakistan
Arif-Ullah Khan Riphah Institute of Pharmaceutical Sciences, Riphah International University,Islamabad,Pakistan
Yousaf Kamal Hamdard Institute of Pharmaceutical Sciences, Hamdard University, Islamabad Campus,,Pakistan
Nadeem Irshad Department of Pharmacy, Quaid-i-Azam University,Islamabad,Pakistan
Abstract
Heart failure is a condition in which the heart's one or both ventricles are unable to either receive an adequate amount of blood or eject an adequate amount of blood. Diabetes is considered one of the major risk factors for cardiovascular diseases. The current research is designed to evaluate the cardioprotective effects of dapagliflozin in streptozotocin and isoproterenol-induced comorbid rats. The COX-2, TNF-a, NF-?B, NLRP3, PPAR-?, CKMB, TROPI, AR, GP and SGLT were docked against dapagliflozin, propranolol and metformin. Dapagliflozin restored adequate blood flow and halted myofibril damage. Moreover, it's evident from this study that dapagliflozin significantly decreased serum concentration of various blood markers, decreased relative growth rate and QT interval prolongation, as compared to the negative control group. However, it improved the ventricular ejection fraction in rats of the treatment group. The GST, GSH and CAT levels were increased, as compared to normal. On the contrary, a decrease in LPO concentrations was observed. Evaluation of the coronal section of heart tissues showed the anti-inflammatory expressions evaluated through H & E staining and immunohistochemical techniques and with ELISA and PCR. In a nutshell, dapagliflozin reverses myocardial necrosis and apoptosis.
Publication Details
Page(s) 337-347
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 37, Issue: 2, Year: 2024

Request the full text from PASTIC

Keywords
ELISA, Docking, Dapagliflozin, cardioprotective, PCR
0

Citations

0

Downloads

84

Views